IONIS PHARMACEUTICALS, INC.

Lobbying client · California · filed 2025 to 2026

Biotechnology company.

$1,160,000 Reported spend

14 Filings counted

1 Outside firm hired

13 Bills named

Spend is reported income plus in-house expenses across 14 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

Who filed for this client 2

IONIS PHARMACEUTICALS, INC. $910,000 In-house, the client's own filings · 7 filings
LMH STRATEGIC SOLUTIONS $250,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 13

H.R. 1262
Mikaela Naylon Give Kids a Chance Act

13 filings
H.R. 1672
Maintaining Investments in New Innovation Act

13 filings
S. 932
Give Kids a Chance Act of 2025

13 filings
H.R. 946
ORPHAN Cures Act

11 filings
S. 1862
ORPHAN Cures Act

9 filings
H.R. 1414
Cameron’s Law

7 filings
H.R. 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…

3 filings
S. 832
EPIC Act of 2025

3 filings
H.R. 5547
Maintaining Investments in New Innovation Act

1 filing
H.R. 7384
Creating Hope Reauthorization Act of 2024

1 filing
S. 476
Maintaining Investments in New Innovation Act

1 filing
H.R. 1509
Accelerating Kids’ Access to Care Act of 2025

1 filing
S. 752
Accelerating Kids’ Access to Care Act

1 filing

Reported by year 2 years

2026 $540,000 6 filings
2025 $620,000 8 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 14
SENATE 14

Recent filings 14 total

Q3 report

LMH STRATEGIC SOLUTIONS

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 19, 2026

View → Q3 report

IONIS PHARMACEUTICALS, INC.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $150,000 expenses · posted Oct 15, 2026

View → Q2 report

IONIS PHARMACEUTICALS, INC.

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $150,000 expenses · posted Jul 17, 2026

View → Q2 report

LMH STRATEGIC SOLUTIONS

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 5, 2026

View → Q1 report

LMH STRATEGIC SOLUTIONS

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 17, 2026

View → Q1 report

IONIS PHARMACEUTICALS, INC.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $150,000 expenses · posted Apr 9, 2026

View → Q4 report

IONIS PHARMACEUTICALS, INC.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $140,000 expenses · posted Jan 18, 2026

View → Q4 report

LMH STRATEGIC SOLUTIONS

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 12, 2026

View → Q3 report

LMH STRATEGIC SOLUTIONS

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2025

View → Q3 report

IONIS PHARMACEUTICALS, INC.

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $140,000 expenses · posted Oct 15, 2025

View → Q2 report

IONIS PHARMACEUTICALS, INC.

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $90,000 expenses · posted Jul 16, 2025

View → Q2 report

LMH STRATEGIC SOLUTIONS

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 15, 2025

View → Q1 report

LMH STRATEGIC SOLUTIONS

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 18, 2025

View → Q1 report

IONIS PHARMACEUTICALS, INC.

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $90,000 expenses · posted Apr 16, 2025

View →

Keep going

Filings through October 19, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.